Japanese startup Iwaya Giken is launching a space tourism business to take sightseers on balloon rides 25 kilometers into the stratosphere
Iwaya Giken noted that while passengers need not undergo special training to make the trip but ticket prices would not be cheap, initially starting at around 24 million yen ($178,100) per person.
Company President Keisuke Iwaya said they will be able to reduce the price to the 1 million yen to 2 million yen range in the future.
Iwaya Giken may begin offering the service by the end of the year.
The service lets passengers ride on the balloon that would ascend for two hours, and stay in the stratosphere for an hour, letting them enjoy the view.
The cabin of the 41-meter-high balloon, which seats two people, is spherical and has a 1.5-meter diameter.
The balloon measures 41 meters high and has a spherical two-seater cabin, which is 1.5 meters in diameter.
The cabin was designed to be impervious to variations in air pressure and temperature. In the event of an emergency, it may be converted into a parachute and outfitted with life support systems.
Iwaya claimed that it created everything in-house to ensure safety, including its communication devices.
By the end of this year, the company hopes to hire five passengers and a pilot for the initial batch of flights, which it hopes to begin from Hokkaido.
It has conducted more than 300 flight tests, with the highest point reaching about 40 kilometers into the sky.
The firm is partnering with a major travel agency, JTB Corp., to organize the tours.
After analyzing the results of the experiments and test flights, JTB Corp. will determine whether it is ready to start selling package deals.


Wall Street Futures Slip as Tech Stocks Struggle Ahead of Key US Economic Data
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Debate over H-1B visas shines spotlight on US tech worker shortages
Why a ‘rip-off’ degree might be worth the money after all – research study
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Youth are charting new freshwater futures by learning from the water on the water
Shell M&A Chief Exits After BP Takeover Proposal Rejected
What’s the difference between baking powder and baking soda? It’s subtle, but significant
U.S. Dollar Steadies Near October Lows as Rate Cut Expectations Keep Markets on Edge
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Silver Prices Hit Record High as Safe-Haven Demand Surges Amid U.S. Economic Uncertainty 



